Nektar Therapeutics: Ownership

Ownership Information
Shares Outstanding 93.00 Mil
Institutional Ownership (%)84.54
Top 10 Institutions (%)58.50
Mutual Fund Ownership (%)1.98
5%/Insider Ownership (%).76
Float (%)99.24
Ownership Activity
Description# of HoldersShares
Total Positions 14778,620,816
New Positions350
Soldout Positions640
Net Position Change-31-5,489,161
Buyers7810,151,998
Sellers109-15,641,159
advertisement
Institution Name Shs Held Shs Chg %Chg $Chg* %Out %Port Rpt Date
OppenheimerFunds, Inc. 18,477,564 29,230 0.2 20,298,096 19.8 0.3 06-30-09
HealthCor Management, L.P. 9,050,000 50,000 0.6 10,134,000 9.7 2.0 06-30-09
Columbia Wanger Asset Management, L.P. 5,739,000 -261,200 -4.4 17,016,564 6.2 0.3 09-30-09
Biotechnology Value Fund, Inc. 5,416,400 -3,596,300 -39.9 -13,480,181 5.8 15.3 06-30-09
Barclays Global Investors, N.A. 5,311,880 -299,804 -5.3 4,174,005 5.7 0.0 06-30-09
Vanguard Group, Inc. 3,616,538 327,774 10.0 5,708,728 3.9 0.0 06-30-09
Granahan Investment Management, Inc. 3,372,240 530 0.0 10,996,937 3.6 1.3 09-30-09
Driehaus Capital Management, LLC 2,357,242 2,357,242 100.0 15,274,928 2.5 1.0 06-30-09
Renaissance Technologies Corp. 2,051,400 408,452 24.9 4,437,582 2.2 0.1 06-30-09
State Street Global Advisors (US) 1,487,167 -357,206 -19.4 -304,328 1.6 0.0 06-30-09
Dimensional Fund Advisors, LP 1,255,706 -50,026 -3.8 3,769,433 1.3 0.0 09-30-09
Federated Investors, Inc. 1,057,325 38,575 3.8 3,696,846 1.1 0.1 09-30-09
RS Investments 1,003,630 24,190 2.5 3,428,585 1.1 0.1 09-30-09
The Boston Company Asset Management, LLC 985,817 985,817 100.0 9,601,858 1.1 0.0 09-30-09
TIAA-CREF 887,834 -48,604 -5.2 2,579,385 1.0 0.0 09-30-09
*Category Headings:
Shs Held - shares held at report date
Shs Chg - position change within reporting period
%Chg - % change
$Chg - market value of the position change
%Out - % of shares outstanding
%Port - % Portfolio
Rpt Date - report date
Page generated 11/25/2009 8:22 AM Eastern Time